Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
SGI-1027 and Everolimus Synergize via Lysosomal Membrane Per
2026-08-02
The referenced study uncovers how SGI-1027, a DNMT1 inhibitor, enhances the antitumor efficacy of everolimus in renal cell carcinoma by triggering lysosomal membrane permeability, leading to apoptosis and GSDME-dependent pyroptosis. This combinatorial approach addresses everolimus resistance and highlights the importance of lysosomal dynamics in advanced RCC therapy.
-
TRPV1 Activation Drives Allokinesis in Chronic Dermatitis Mo
2026-08-01
A recent study reveals that 20-HETE activates TRPV1 channels on MrgprA3+ neurons, driving abnormal itch (allokinesis) in chronic dermatitis. This mechanistic insight highlights potential therapeutic targets for chronic itch and supports the use of capsaicin analogs for precise TRPV1 modulation in research.
-
N1-Methylpseudouridine in mRNA Vaccines: Fidelity and Implic
2026-07-31
Kim et al. (2022) provide robust evidence that N1-methylpseudouridine, a key nucleotide modification in COVID-19 mRNA vaccines, preserves translational fidelity and does not compromise protein coding accuracy. Their findings reassure the safety of pseudo-modified uridine triphosphate analogues for advanced mRNA therapeutics, informing best practices for mRNA vaccine development and gene therapy design.
-
Sunitinib and Ferroptosis: Next-Generation Insights in RCC R
2026-07-31
Discover how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, leverages ferroptosis pathways to overcome resistance in renal cell carcinoma studies. This article uniquely explores cutting-edge findings for advancing cancer research.
-
Translating Apoptosis Detection: Mechanistic Insights and St
2026-07-30
Explore how mechanistic understanding of apoptosis—integrating oxidative stress, DNA fragmentation, and advanced detection methods—guides translational research. This thought-leadership article weaves together the biological rationale, protocol strategies, and strategic imperatives for researchers, highlighting the APExBIO TUNEL Apoptosis Detection Kit (DAB) as a pivotal tool for robust, reproducible DNA fragmentation detection across tissue and cell models.
-
Sodium Nitroprusside: Advancing Sex-Difference Vascular Rese
2026-07-30
Explore how sodium nitroprusside, a potent nitric oxide donor, is transforming the study of sex differences in hypertension and vascular reactivity. This article delivers mechanistic insights, protocol guidance, and strategic perspectives to empower translational researchers designing preclinical cardiovascular studies.
-
Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Cance
2026-07-29
Carboplatin is a platinum-based DNA synthesis inhibitor with robust, quantifiable efficacy in preclinical oncology models. Its cytotoxic activity against ovarian and lung cancer cell lines is well-documented, and its mechanistic action is leveraged for both in vitro and in vivo cancer research. This article clarifies evidence, optimal use, and common misconceptions to help researchers select and apply Carboplatin with confidence.
-
Bismuth Subsalicylate in GI Disorder Research: Protocols & I
2026-07-29
Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) is redefining gastrointestinal disorder research through its robust prostaglandin G/H synthase 1/2 inhibition and unique membrane-protective properties. This guide delivers actionable workflow enhancements, troubleshooting tactics, and comparative advantages, empowering researchers to drive translational progress with APExBIO’s high-purity reagent.
-
GPX4-Driven Glutathione Consumption Fuels Platinum Resistanc
2026-07-28
This study uncovers how glutathione peroxidase 4 (GPX4)-mediated high glutathione consumption underlies acquired platinum chemoresistance in lung cancer brain metastases. The findings identify a Wnt/NR2F2/GPX4 axis that suppresses ferroptosis, offering new mechanistic insights and experimental targets for overcoming therapeutic resistance.
-
SM-102: Predictive Optimization for mRNA Vaccine Lipid Nanop
2026-07-28
Explore SM-102, a synthetic lipid, in the predictive optimization of mRNA vaccine delivery systems. This article uniquely examines how machine learning and molecular insights inform assay design and practical workflow decisions for advanced LNP development.
-
ONX-0914 (PR-957) in Autoimmune & Inflammation Research
2026-07-27
ONX-0914 (PR-957) empowers researchers to selectively inhibit the immunoproteasome, enabling precise modulation of cytokine production in autoimmune and inflammatory disease models. This article explores advanced protocol integration, troubleshooting strategies, and translational insights, leveraging cutting-edge findings on LMP7’s role in immune regulation.
-
Frizzled5-Cholesterol Interaction Drives Wnt Signaling in Ca
2026-07-27
The reference study uncovers Frizzled5 (Fzd5) as a unique Wnt receptor directly binding cholesterol, enabling palmitoylation and plasma membrane trafficking, which are crucial for Wnt/β-catenin signaling and pancreatic cancer cell growth. This mechanistic link between cholesterol metabolism and oncogenic signaling highlights new avenues for targeted therapeutic intervention.
-
Viral Inducers of RIPK3 Degradation: Regulating Necroptosis
2026-07-26
Liu et al. identified viral proteins in orthopoxviruses that target the necroptosis adaptor RIPK3 for ubiquitin-proteasome-dependent degradation, suppressing necroptosis and modulating virus-induced inflammation. This discovery provides new mechanistic insight into host–pathogen interactions and highlights tools and pathways central to antiviral immunity research.
-
SB743921: Advanced Insights into KSP Inhibition and Assay De
2026-07-25
Explore SB743921, a potent kinesin spindle protein inhibitor, through a deep dive into its mechanistic action, anti-proliferative effects in cancer research, and the nuanced interpretation of in vitro assay results. This article uniquely integrates recent methodological innovations to guide optimal experimental design.
-
Single-Cell Analysis Reveals Ciprofloxacin-Tetracycline Anta
2026-07-24
This study uncovers how the combination of ciprofloxacin hydrochloride and tetracycline leads to antagonistic effects at the single-cell level, driven by suppressed bacterial cell death and heterogeneity in the DNA damage response. These insights underline the importance of nutrient conditions and cellular diversity for optimizing antibiotic combinations in research and clinical microbiology.